Literature DB >> 30929334

[Consensus on clinical application of transient elastography detecting liver fibrosis: a 2018 update].

.   

Abstract

Transient elastography is a noninvasive, rapid ultrasonic elastography, and assess liver fibrosis by detetcting liver stiffness. Current consensus focuses on understanding influence factors on operation and diagnosis, recommendations for clinical application on detetcting liver fibrosis of chronic liver disease and monitoring development of related complication hepatocelullar carcinoma, high risk esophageal varices, and also summarizes the potential aplication on liver disease screening and liver fibrosis regression assessment.

Entities:  

Keywords:  Consensus; Diagnosis; Liver disease; Liver fibrosis; Transient elastography

Mesh：

Year:  2019        PMID： 30929334     DOI： 10.3760/cma.j.issn.1007-3418.2019.03.004

Source DB:  PubMed          Journal:  Zhonghua Gan Zang Bing Za Zhi        ISSN： 1007-3418


  6 in total

1.  Bile acid metabolism and liver fibrosis following treatment with bifid triple viable capsules in nonalcoholic fatty liver disease.

Authors:  Yuqing Zhou; Wen Lu; Guorong Yang; Yifeng Chen; Jiwei Cao; Chunli Zhou
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

2.  Tenofovir is superior to entecavir in reducing HCC for patients with HBV-related compensated cirrhosis at high HCC risk scores.

Authors:  Yan Huang; Lichang Chen; Rui Huang; Chuanwu Zhu; Jia Shang; Yunsong Qian; Jianqi Lian; Longgen Liu; Jianning Jiang; Chenghai Liu; Honglian Gui; Qing Xie
Journal:  Ther Adv Chronic Dis       Date:  2022-06-21       Impact factor: 4.970

3.  Effect of a High Protein, Low Glycemic Index Dietary Intervention on Metabolic Dysfunction-Associated Fatty Liver Disease: A Randomized Controlled Trial.

Authors:  Ping Sun; Liping Huang; Ping Shuai; Zhengwei Wan; Yingying Liu; Jianqiang Xue; Yuping Liu
Journal:  Front Nutr       Date:  2022-04-27

Review 4.  Chinese guidelines on the management of liver cirrhosis (abbreviated version).

Authors:  Xiao-Yuan Xu; Hui-Guo Ding; Wen-Gang Li; Jing-Hang Xu; Ying Han; Ji-Dong Jia; Lai Wei; Zhong-Ping Duan; En-Qiang Ling-Hu; Hui Zhuang
Journal:  World J Gastroenterol       Date:  2020-12-07       Impact factor: 5.742

5.  Non-alcoholic fatty liver disease is a risk factor for occurrence of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients: A prospective four-years follow-up study.

Authors:  Dong Ji; Guo-Feng Chen; Xiao-Xia Niu; Mingjie Zhang; Cheng Wang; Qing Shao; Vanessa Wu; Yudong Wang; Gregory Cheng; Selwyn J Hurwitz; Raymond F Schinazi; George Lau
Journal:  Metabol Open       Date:  2021-03-26

6.  Effectiveness of Tenofovir Alafenamide in Chronic Hepatitis B Patients with Normal Alanine Aminotransferase and Positive Hepatitis B Virus DNA.

Authors:  Wen-Kang Gao; Yan-Yun Shu; Yue Chen; Yan Ai; Xiao-Qian Yang; Fan Du; Jin Ye
Journal:  J Clin Transl Hepatol       Date:  2021-06-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.